Board of Directors

Scott St John profile

Scott St John, Chair

Scott is Chairman of ANZ Bank New Zealand Limited and Mercury Limited, and a director of the ANZ Group Board and NEXT Foundation. Scott was Chief Executive Officer of First NZ Capital from 2002 to 2017. He is a member of Chartered Accountants Australia and New Zealand, a fellow of the Institute of Finance Professionals of New Zealand and a Chartered Member of the Institute of Directors.

Bachelor of Commerce, Diploma in Business

Lewis Gradon profile

Lewis Gradon, Managing Director & Chief Executive Officer

Lewis became Managing Director and Chief Executive Officer in April 2016. Prior to that, he spent 15 years as Senior Vice President – Products & Technology, and six years as General Manager – Research and Development. During his 41-year tenure with Fisher & Paykel Healthcare, he has held various engineering positions overseeing the development of our range of products as well the development of our manufacturing, quality, intellectual property, supply chain and clinical research functions.
Bachelor of Science – Physics
Michael Daniell profile

Michael Daniell

Mike was Managing Director and Chief Executive Officer of Fisher & Paykel Healthcare from November 2001 to March 2016. He was General Manager of Fisher & Paykel’s medical division from 1990 to 2001 and previously held various technical management and product design roles within the company. Mike is a director of Cochlear Limited, Tait International Limited and the Medical Research Commercialisation Fund. Michael was named a Knight Companion of the New Zealand Order of Merit in June 2021.

Bachelor of Engineering (Hons)
Pip Greenwood profile

Pip Greenwood

Pip is the Chair of Westpac New Zealand Limited and also Chair of The a2 Milk Company Limited. Pip was a partner at Russell McVeagh between 2001 and 2019 and served as the firm’s Board Chair. She has advised on many high-profile corporate transactions. Pip also served as a member of the New Zealand Takeovers Panel from 2007 to 2011.
Bachelor of Laws

Lisa McIntyre profile

Lisa McIntyre

Lisa is a director of The University of Sydney, Studiosity, Nanosonics and Baymatob. She has previously been a director of a range of health entities, including those in healthcare insurance, clinical service delivery and medical research and innovation. Lisa spent 20 years as a senior strategy partner with LEK Consulting providing advice to companies in North America, Asia and Australia.

PhD Physical Chemistry, Bachelor of Science – Biochemistry and Pure Maths 
Graham McLean profile

Graham McLean

Graham is a director and CEO of CleanSpace Technology and chair of Universal Biosensors. Graham previously spent 16 years as an executive at leading medical device manufacturer Stryker Corporation, most recently as President of the Asia Pacific region situated in Hong Kong and Singapore. Prior to joining Stryker, Graham had finance, audit and commercial positions at Lion Nathan, McVitie’s Limited and Unilever.

Bachelor of Science - Geography

Neville Mitchell profile

Neville Mitchell 

Neville was Chief Financial Officer and Company Secretary of Cochlear between 1995 and 2017. He is a director of Sonic Healthcare and Sigma Healthcare, and is a former director of The Board of Tax, South Eastern Sydney Local Health District, Osprey Medical and Sirtex Medical. Previously, he served on the New South Wales Medical Devices Fund, was Chairman of the Group of 100, and Chairman, Standing Committee (Accounting and Auditing) for the Australian Securities and Investments Commission.

Bachelor of Commerce

Cather Simpson profile

Cather Simpson

Cather is a professor of physics and chemical sciences at the University of Auckland and a partner at Pacific Channel, with expertise in lasers and photonics. She is a director of the International Society for Optics & Photonics (SPIE) and the Dodd-Walls Centre for Photonic & Quantum Technologies, and CEO of Orbis Diagnostics. In 2010, Cather established the Photon Factory at the University of Auckland, from which she co-founded three hard-tech start-ups, including Engender Technologies, where she served as Chief Science Officer from 2011 to 2021.

PhD Medical Sciences, Bachelor of Arts – Interdisciplinary Studies